FI-Lab:急诊成人实验室衰弱指数的多队列评估
该回顾性多队列研究利用美国MIMIC-IV-ED、英国KCH急诊数据及UK Biobank社区队列,评估基于常规实验室检查自动构建的衰弱指数(FI-Lab)对急性照护的适用性。由25项常见检测(至少15项)计算的FI-Lab对1年全因死亡的预测接近实际年龄并优于NEWS2,在三个队列中每标准差增加的死亡风险比分别为2.04、2.55和1.87,且在不同年龄、性别和种族中表现一致。
要点
- FI-Lab由20-40项常规实验室检查自动计算,无需额外检测或手工录入。
- FI-Lab对1年全因死亡的预测能力接近年龄,且优于NEWS2。
- FI-Lab在不同医疗场景和人群中表现稳健,可作为临床判断的实用补充。
核心结论
- FI-Lab提供了一种自动化、可扩展的患者脆弱性测量工具,在多种医疗场景和人群中表现稳健。
研究设计与样本
- 回顾性多队列研究,使用美国MIMIC-IV-ED(2011-2019)和英国KCH(2017-2020)的急诊就诊数据,以及UK Biobank社区队列(2006-2010)。
- 分析样本包括MIMIC-IV-ED的227,736次就诊(113,032名患者)、KCH的152,305次就诊(96,843名患者)和UK Biobank的492,703人。
主要发现
- 由25项常见检测(至少需15项)计算的FI-Lab对1年全因死亡的预测接近实际年龄,并超过NEWS2。
- 在联合模型中,FI-Lab每增加一个标准差的风险比在MIMIC-IV-ED为2.04(95%CI [1.99, 2.09];p<0.001),KCH为2.55(95%CI [2.42, 2.69];p<0.001),UK Biobank为1.87(95%CI [1.80, 1.94];p<0.001)。
- 性能在不同年龄、种族、性别和模型类型中表现一致,区分度在20-40项检测时达到平台。
关键数值与推荐
- FI-Lab推荐的构建方式为使用25项常见检测,最少需要15项检测结果。
- 核心检测组合为20-40项常规实验室检查即可充分捕捉信号。
临床怎么用
- FI-Lab可基于常规急诊实验室数据自动计算,无需额外检测或手工录入,作为临床判断的补充工具评估患者脆弱性。
局限性
- 本研究为回顾性研究,未来需前瞻性评估(可能通过随机对照试验)探讨对日常使用的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laboratory-based frailty indices (FI-Lab) have shown promise in geriatric medicine research. We aimed, in diverse samples, to determine the optimal construction of an FI-Lab for acute care and evaluate its validity as a measure of latent health status across the adult life span. METHODS AND FINDINGS: Our retrospective multicohort study used emergency department encounters in Boston, USA (MIMIC-IV-ED; 2011-2019) and London, UK (King's College Hospital (KCH); 2017-2020); and a community-based cohort in the UK (UK Biobank; 2006-2010). We evaluated FI-Lab configurations by varying test selection strategies, number of tests, and minimum test thresholds. Sensitivity analyses examined performance across age, ethnicities, sexes, and model types to identify potential blind spots. The primary outcome was 1-year all-cause mortality. We analysed 227,736 visits (113,032 patients) from MIMIC-IV-ED; 152,305 visits (96,843 patients) from KCH; and 492,703 UK Biobank. An FI-Lab calculated from 25 commonly ordered tests (minimum 15 required) demonstrated hazard ratios for 1-year mortality approaching those of chronological age and exceeding the National Early Warning Score 2 (NEWS2). In combined models, hazard ratios for FI-Lab per standard deviation increase were 2.04 (95 %CI [1.99, 2.09]; p < 0.001) in MIMIC-IV-ED, 2.55 (95 %CI [2.42, 2.69]; p < 0.001) in KCH, and 1.87 (95% CI [1.80, 1.94]; p < 0.001) in UK Biobank. Performance was consistent across subject groupings. Discrimination plateaued at 20-40 tests. This was a retrospective study; future work exploring the impact on everyday use requires prospective evaluation, potentially in a randomised controlled trial. CONCLUSIONS: The FI-Lab provides an automated, scalable measure of patient vulnerability that is robust across healthcare settings and populations. A core set of 20-40 commonly ordered tests is sufficient for signal capture. It offers a pragmatic complement to clinical judgement without requiring manual data entry or additional tests.
引用
- Logan Ellis H, Hanlon P, Dunnell L, et al. Evaluation of the FI-Lab, a laboratory-based, automated frailty index for acute care: A multicohort study. PLoS Med. 2026. PMID: 42678992. doi:10.1371/journal.pmed.1005004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。